Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FK4BH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,937
Award facts
- Contract value 100% obligated
- $30,936.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of AIMOVIG 140 mg/ml autoinjectors, with a ceiling value of approximately $31,000 and an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply vehicle that extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AIMOVIG (erenumab) is a monoclonal antibody therapy used for migraine prevention, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military healthcare systems and personnel. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive capabilities to fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications and brand-name drugs. This delivery order exemplifies the company's role as a critical vendor within the DLA's pharmaceutical supply chain, supporting the Defense Health Agency and other government healthcare systems through competitively awarded contracts featuring firm fixed pricing and flexible delivery mechanisms.
Quick answers
Who was awarded contract SPE2DB25FK4BH?
SPE2DB25FK4BH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FK4BH worth?
The government has obligated $30,937 on SPE2DB25FK4BH.
Is contract SPE2DB25FK4BH an order under another contract?
Yes. SPE2DB25FK4BH is a delivery order under SPE2DB22D3019, an indefinite delivery contract.
Was contract SPE2DB25FK4BH competed?
The extent of competition for SPE2DB25FK4BH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award